| RS2082523114 |
SLC5A2
|
Health Risk |
Likely pathogenic |
Familial renal glucosuria, Familial renal glucosuria |
| RS2082523921 |
KATNIP
|
Health Risk |
Likely pathogenic |
— |
| RS2082525102 |
NDUFS7
|
Health Risk |
Likely pathogenic |
— |
| RS2082528605 |
MLH1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2082532798 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2082534727 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2082548304 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2082558148 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2082559544 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Breast carcinoma |
| RS2082568277 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082573854 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
SPTB-related disorder, SPTB-related disorder |
| RS2082607260 |
GAMT
|
Health Risk |
Pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2082607494 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2082610932 |
LAMA3
|
Health Risk |
Likely pathogenic |
— |
| RS2082617068 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2082618262 |
GAMT
|
Health Risk |
Pathogenic |
Deficiency of guanidinoacetate methyltransferase, Cerebral creatine deficiency syndrome |
| RS2082618808 |
GAMT
|
Health Risk |
Likely pathogenic |
Intellectual disability, Cerebral creatine deficiency syndrome |
| RS2082620820 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2082621259 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS2082622867 |
GAMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS2082623593 |
GAMT
|
Health Risk |
Pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2082624299 |
GAMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS2082632611 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2082632873 |
GAMT
|
Health Risk |
Likely pathogenic |
Deficiency of guanidinoacetate methyltransferase, Deficiency of guanidinoacetate methyltransferase |
| RS2082634017 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Cerebral creatine deficiency syndrome |
| RS2082638172 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082638431 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082642299 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082644196 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082644891 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082645600 |
ATM
|
Health Risk |
Pathogenic |
Breast and/or ovarian cancer, Breast and/or ovarian cancer |
| RS2082646632 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082646919 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082647388 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082647866 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082657747 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082658031 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082660121 |
ARSA
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082663514 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082670823 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2082671645 |
ROBO1
|
Health Risk |
Likely pathogenic |
Bilateral renal agenesis, Neurooculorenal syndrome |
| RS2082672268 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082673250 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082673829 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082676249 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082676596 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082679287 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082679417 |
ARSA
|
Health Risk |
Likely pathogenic |
— |
| RS2082680103 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082680996 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082684340 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082686950 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2082687168 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082687178 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2082689270 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082689435 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082690324 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082692417 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082692831 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082694047 |
ROGDI
|
Health Risk |
Likely pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2082694133 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2082694697 |
ROGDI
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelocerebrohypohidrotic syndrome, Inborn genetic diseases |
| RS2082695884 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Seizure |
| RS2082697802 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082698834 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2082701593 |
ROGDI
|
Health Risk |
Likely pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2082702986 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082703730 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2082710048 |
SPG11
|
Health Risk |
Likely pathogenic |
Abnormal central motor function, Abnormal central motor function |
| RS2082712944 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2082714521 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2082714895 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082715392 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082716347 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082718032 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS2082718424 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2082742684 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS2082749588 |
MLH1
|
Health Risk |
Pathogenic |
— |
| RS2082749902 |
SPG11
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS2082751022 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082811780 |
TLK2
|
Health Risk |
Pathogenic |
— |
| RS2082811958 |
TLK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS2082829594 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS2082832384 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2082833010 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2082838403 |
LAMA3
|
Health Risk |
Likely pathogenic |
— |
| RS2082841677 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2082842632 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS2082843264 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082844329 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2082845191 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2082857900 |
ST3GAL3
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2082861857 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2082862502 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082867555 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082868647 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2082869865 |
SPTB
|
Health Risk |
Likely pathogenic |
— |
| RS2082872908 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2082890188 |
DOHH
|
Health Risk |
Pathogenic |
DOHH related neurodevelopmental disorder, Neurodevelopmental disorder with microcephaly |
| RS2082897416 |
PRMT7
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |